One of the country’s largest startup incubators will soon be moving into the Cortex bioscience district in St. Louis.
The move marks Cambridge Innovation Center’s first expansion out of the Boston area, where it houses more than 500 small to mid-sized companies.
CIC’s president and CEO, Ranch Kimball, says he expects the new St. Louis facility to attract mostly technology startups, but says CIC will be open to a variety of businesses.
The numbers are pretty impressive, more than three dozen new biotech startups now call St. Louis home and collectively they’re hauling in tens of millions of dollars from investors.
One piece of a planned $2.1 billion expansion of the life sciences district Cortex has fallen into place.
The life sciences district known as Cortex has gotten initial approval for the first phase of its $2.1 billion expansion plan.
The city's Tax Increment Financing commission voted today to authorize about $35 million in incentives for the first phase, which totals about $160 million.
The phase includes new office and laboratory space, a new Shriners' Hospital, and a streetscape known as Cortex Commons. Here's how it breaks down:
St. Louis Public Radio is a service of the University of Missouri-St. Louis.